BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9160306)

  • 1. Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.
    Warrick JI; Hovelson DH; Amin A; Liu CJ; Cani AK; McDaniel AS; Yadati V; Quist MJ; Weizer AZ; Brenner JC; Feng FY; Mehra R; Grasso CS; Tomlins SA
    Virchows Arch; 2015 Mar; 466(3):297-311. PubMed ID: 25502898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
    Schallenberg S; Plage H; Hofbauer S; Furlano K; Weinberger S; Bruch PG; Roßner F; Elezkurtaj S; Kluth M; Lennartz M; Blessin NC; Marx AH; Samtleben H; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Horst D; Klatte T; Schlomm T; Zecha H
    Acta Oncol; 2023 Dec; 62(12):1880-1889. PubMed ID: 37938166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high prevalence of functional inactivation by methylation modification of p16INK4A/CDKN2/MTS1 gene in primary urothelial cancers.
    Akao T; Kakehi Y; Itoh N; Ozdemir E; Shimizu T; Tachibana A; Sasaki MS; Yoshida O
    Jpn J Cancer Res; 1997 Nov; 88(11):1078-86. PubMed ID: 9439683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of WNT signalling in urothelial cell carcinoma.
    Ahmad I
    Ann R Coll Surg Engl; 2015 Oct; 97(7):481-6. PubMed ID: 26274747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review.
    Li D; Liu F; Chen Y; Li P; Liu Y; Pang Y
    Diagn Pathol; 2023 Nov; 18(1):120. PubMed ID: 37924117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of urothelial tumorigenesis: insights from genetically engineered mice.
    Wu XR
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):281-90. PubMed ID: 20012171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An accurate diagnostic approach for urothelial carcinomas based on novel dual methylated DNA markers in small-volume urine.
    Wu Y; Cai D; Fan J; Meng C; He S; Li Z; Zhang L; Yang K; Wang A; Li X; Du Y; Xiong S; Xia M; Li T; Dong L; Gong Y; Zhou L; Li X
    Chin Med J (Engl); 2024 Jan; 137(2):232-234. PubMed ID: 37455255
    [No Abstract]   [Full Text] [Related]  

  • 8. Urothelial carcinoma with oncocytic features: an extremely rare case presenting a diagnostic challenge in urine cytology.
    Tajima S
    Int J Clin Exp Pathol; 2015; 8(7):8591-7. PubMed ID: 26339439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 status in multiple human urothelial cancers: assessment for clonality by the yeast p53 functional assay in combination with p53 immunohistochemistry.
    Yamamoto S; Tada M; Lee CC; Masuda C; Wanibuchi H; Yoshimura R; Wada S; Yamamoto K; Kishimoto T; Fukushima S
    Jpn J Cancer Res; 2000 Feb; 91(2):181-9. PubMed ID: 10761705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [p53 mutation in phenacetin-induced urothelial carcinomas].
    Petersen I; Ohgaki H; Ludeke BI; Kleihues P
    Verh Dtsch Ges Pathol; 1993; 77():252-5. PubMed ID: 7511292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.
    Watanabe J; Nishiyama H; Okubo K; Takahashi T; Toda Y; Habuchi T; Kakehi Y; Tada M; Ogawa O
    Urology; 2004 May; 63(5):989-93. PubMed ID: 15135005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.